GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | 25.64 | 35.77 | 30.89 | 23.51 | 30.67 |
What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2026 | 25.64 |
| Mar2025 | 35.77 |
| Mar2024 | 30.89 |
| Mar2023 | 23.51 |
| Mar2022 | 30.67 |
How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2026 | 25.64 | -28.32 | |
| Mar2025 | 35.77 | 15.80 | |
| Mar2024 | 30.89 | 31.39 | |
| Mar2023 | 23.51 | -23.35 | |
| Mar2022 | 30.67 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,518.2 Cr | 2.2% | 11% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 2.2% |
11% |
-25.7% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses